Enoxaparin: In the Prevention of Venous Thromboembolism in Medical Patients

ISSN： 1175-3277

Source： American Journal of Cardiovascular Drugs, Vol.1, Iss.6, 2001-06, pp. : 477-481

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacological Prevention of Venous Thromboembolism in Medical Patients at Risk

By Wolozinsky Mia Yavin Yshai Y. Cohen Alexander T.

American Journal of Cardiovascular Drugs, Vol. 5, Iss. 6, 2005-01 ,pp. : 409-415

Adis International

Access to resources Recommend Favorite

Fondaparinux versus enoxaparin for the prevention of venous thromboembolism

By Doggrell Sheila A

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 4, 2002-04 ,pp. : 455-457

Informa Healthcare

Access to resources Recommend Favorite

Enoxaparin: A Pharmacoeconomic Review of its Use in the Prevention and Treatment of Venous Thromboembolism and in Acute Coronary Syndromes

By Bergqvist D.

PharmacoEconomics, Vol. 20, Iss. 4, 2002-04 ,pp. : 225-243

Adis International

Access to resources Recommend Favorite

Cost Effectiveness of Rivaroxaban versus Enoxaparin for Prevention of Post-Surgical Venous Thromboembolism from a US Payer's Perspective

By Duran Aurea

PharmacoEconomics, Vol. 30, Iss. 2, 2012-02 ,pp. : 87-101

Adis International

Access to resources Recommend Favorite

A Cost-Effectiveness Analysis of Fondaparinux Sodium Compared with Enoxaparin Sodium as Prophylaxis Against Venous Thromboembolism: Use in Patients Undergoing Major Orthopaedic Surgery

By Sullivan S.D.

PharmacoEconomics, Vol. 22, Iss. 9, 2004-01 ,pp. : 605-620

Adis International

Access to resources Recommend Favorite